Cargando…

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Quwaider, Dalia, Corchete, Luis A., Misiewicz-Krzeminska, Irena, Sarasquete, María E., Pérez, José J., Krzeminski, Patryk, Puig, Noemí, Mateos, María Victoria, García-Sanz, Ramón, Herrero, Ana B., Gutiérrez, Norma C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395780/
https://www.ncbi.nlm.nih.gov/pubmed/28420429
http://dx.doi.org/10.1186/s13045-017-0461-8
_version_ 1783229933897646080
author Quwaider, Dalia
Corchete, Luis A.
Misiewicz-Krzeminska, Irena
Sarasquete, María E.
Pérez, José J.
Krzeminski, Patryk
Puig, Noemí
Mateos, María Victoria
García-Sanz, Ramón
Herrero, Ana B.
Gutiérrez, Norma C.
author_facet Quwaider, Dalia
Corchete, Luis A.
Misiewicz-Krzeminska, Irena
Sarasquete, María E.
Pérez, José J.
Krzeminski, Patryk
Puig, Noemí
Mateos, María Victoria
García-Sanz, Ramón
Herrero, Ana B.
Gutiérrez, Norma C.
author_sort Quwaider, Dalia
collection PubMed
description BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we explore the role of DEPTOR, an mTOR inhibitor, in the terminal differentiation of myeloma cells, and its potential impact on patient survival. METHODS: The expression level of DEPTOR in MM cell lines and B cell populations was measured by real-time RT-PCR, and/or Western blot analysis. DEPTOR protein level in MM patients was quantified by capillary electrophoresis immunoassay. RNA interference was used to downregulate DEPTOR in MM cell lines. RESULTS: DEPTOR knockdown in H929 and MM1S cell lines induced dedifferentiation of myeloma cells, as demonstrated by the upregulation of PAX5 and BCL6, the downregulation of IRF4, and a clear reduction in cell size and endoplasmic reticulum mass. This effect seemed to be independent of mTOR signaling, since mTOR substrates were not affected by DEPTOR knockdown. Additionally, the potential for DEPTOR to be deregulated in MM by particular miRNAs was investigated. The ectopic expression of miR-135b and miR-642a in myeloma cell lines substantially diminished DEPTOR protein levels, and caused dedifferentiation of myeloma cells. Interestingly, the level of expression of DEPTOR protein in myeloma patients was highly variable, the highest levels being associated with longer progression-free survival. CONCLUSIONS: Our results demonstrate for the first time that DEPTOR expression is required to maintain myeloma cell differentiation and that high level of its expression are associated with better outcome. Primary samples used in this study correspond to patients entered into GEM2010 trial (registered at www.clinicaltrials.gov as #NCT01237249, 4 November 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0461-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5395780
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53957802017-04-20 DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma Quwaider, Dalia Corchete, Luis A. Misiewicz-Krzeminska, Irena Sarasquete, María E. Pérez, José J. Krzeminski, Patryk Puig, Noemí Mateos, María Victoria García-Sanz, Ramón Herrero, Ana B. Gutiérrez, Norma C. J Hematol Oncol Research BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we explore the role of DEPTOR, an mTOR inhibitor, in the terminal differentiation of myeloma cells, and its potential impact on patient survival. METHODS: The expression level of DEPTOR in MM cell lines and B cell populations was measured by real-time RT-PCR, and/or Western blot analysis. DEPTOR protein level in MM patients was quantified by capillary electrophoresis immunoassay. RNA interference was used to downregulate DEPTOR in MM cell lines. RESULTS: DEPTOR knockdown in H929 and MM1S cell lines induced dedifferentiation of myeloma cells, as demonstrated by the upregulation of PAX5 and BCL6, the downregulation of IRF4, and a clear reduction in cell size and endoplasmic reticulum mass. This effect seemed to be independent of mTOR signaling, since mTOR substrates were not affected by DEPTOR knockdown. Additionally, the potential for DEPTOR to be deregulated in MM by particular miRNAs was investigated. The ectopic expression of miR-135b and miR-642a in myeloma cell lines substantially diminished DEPTOR protein levels, and caused dedifferentiation of myeloma cells. Interestingly, the level of expression of DEPTOR protein in myeloma patients was highly variable, the highest levels being associated with longer progression-free survival. CONCLUSIONS: Our results demonstrate for the first time that DEPTOR expression is required to maintain myeloma cell differentiation and that high level of its expression are associated with better outcome. Primary samples used in this study correspond to patients entered into GEM2010 trial (registered at www.clinicaltrials.gov as #NCT01237249, 4 November 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0461-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-18 /pmc/articles/PMC5395780/ /pubmed/28420429 http://dx.doi.org/10.1186/s13045-017-0461-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Quwaider, Dalia
Corchete, Luis A.
Misiewicz-Krzeminska, Irena
Sarasquete, María E.
Pérez, José J.
Krzeminski, Patryk
Puig, Noemí
Mateos, María Victoria
García-Sanz, Ramón
Herrero, Ana B.
Gutiérrez, Norma C.
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title_full DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title_fullStr DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title_full_unstemmed DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title_short DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
title_sort deptor maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395780/
https://www.ncbi.nlm.nih.gov/pubmed/28420429
http://dx.doi.org/10.1186/s13045-017-0461-8
work_keys_str_mv AT quwaiderdalia deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT corcheteluisa deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT misiewiczkrzeminskairena deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT sarasquetemariae deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT perezjosej deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT krzeminskipatryk deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT puignoemi deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT mateosmariavictoria deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT garciasanzramon deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT herreroanab deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma
AT gutierreznormac deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma